SAN DIEGO, Calif., May 22, 2013 — KFx Medical Corporation announced that it received Notice of Allowance of claims in two additional patent applications broadly covering its AppianFx anchors and anchors for use in knotless double row rotator cuff repair.
“Our patent counsel, Knobbe, Martens, Olson and Bear LLP has done a superb job for us in the prosecution of our patent estate. Once issued these new patents will bring us to 11 issued U.S. patents, 7 pending U.S. applications, 3 issued foreign patents, and 3 pending foreign applications. We are quite pleased with Knobbe’s patent prosecution work as well as their work on our litigation with Arthrex. Additionally, it is rewarding that our AppianFx which is being received very well in its initial use for biceps repair, received patent protection,” indicated Tate Scott, president and CEO.
On August 1, 2011, KFx filed the complaint against Arthrex alleging claims of induced and contributory infringement of United States Patent Number 7,585,311. Since that time KFx has been awarded an additional three patents covering knotless double row repair, two of which were added to the suit versus Arthrex (United States Patent Numbers 8,100,942 and 8,109,969). In October 2012 KFx Medical Corporation announced that the United States District Court ruled all 6 of the 6 disputed claims in favor of KFx in the Markman Hearing. Presently that case is scheduled to be heard in August 2013 in San Diego.
The new AppianFx line of implants from KFx reattach tissue to bone in shoulder, knee, foot and ankle procedures which combined exceed well over 1 million annual surgical procedures in the United States. Product offerings include those that directly place and secure tissue into bone both with and without the use of sutures.
About KFx Medical
Headquartered in Carlsbad, Calif., KFx Medical Corporation was founded in 2003 to develop products for tissue fixation in a variety of orthopedic surgical procedures performed on the shoulder, knee, foot, and ankle. KFx provides simple systems for orthopedic surgeons focused on sports medicine. The new AppianFx line of implants from KFx reattach tissue to and in bone in shoulder, knee, foot and ankle procedures which combined exceed well over 1 million annual surgical procedures in the United States. Product offerings include those that directly place and secure tissue into bone both with and without the use of sutures.
The company is privately held — Investors include Alloy Ventures, Charter Life Sciences, Arboretum Ventures, Montreux Equity Partners, and MB Venture Partners.
KFx Medical Corporation
Tate Scott, 760-444-8820
President & CEO